CFRUY
PINK Compagnie Financiere Richemont SA Unsponsored ADR$20.86 ↑ +0.00 (+0.00%) Trading Up from the previous close of $20.86, $0.28 below the day’s high of $21.14
- YTD change
- -3.11%
- vs 20-day SMA
- -1.65%
- vs 200-day SMA
- -0.50%
Price ranges
Price & Performance
+2.81 (+15.57%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 16.1% away from all-time highs of $24.86
- CFRUY is down 3% since the beginning of the year
- CFRUY is up 8% over the past 12 months
- CFRUY is down 10% over the past 1 month
CFRUY reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +8.6%.
- Previous minute
- +$0.00
- Last hour
- -$0.02
- Last 5 days
- +0.92%
- vs 8-day SMA
- +0.05%
No alerts for CFRUY in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Compagnie Financière Richemont SA engages in the design, manufacture, and distribution of luxury goods. It operates through the following segments: Jewellery Maisons, Specialist Watchmakers, and Other. The Jewellery Maisons segment designs, manufactures, and distributes jewellery products comprised of Buccellati, Cartier, and Van Cleef and Arpels. The Specialist Watchmakers segment offers precision timepieces, which comprises Piaget, A. Lange and Sohne, Jaeger-LeCoultre, Vacheron Constantin, Officine Panerai, IWC Schaffhausen, Baume & Mercier, and Roger Dubuis. The Other segment includes Alaia, Chloe, Delvaux, Dunhill, Gianvito Rossi, Montblanc, Peter Millar, Purdey, Serapian, Watchfinder, investment property companies, and other manufacturing entities. The company was founded by Johann Peter Rupert in September 1988 and is headquartered in Bellevue, Switzerland.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.